AU4190989A - Insertion of heterologous gene from a pathogen to produce a recombinant capripoxvirus - Google Patents

Insertion of heterologous gene from a pathogen to produce a recombinant capripoxvirus

Info

Publication number
AU4190989A
AU4190989A AU41909/89A AU4190989A AU4190989A AU 4190989 A AU4190989 A AU 4190989A AU 41909/89 A AU41909/89 A AU 41909/89A AU 4190989 A AU4190989 A AU 4190989A AU 4190989 A AU4190989 A AU 4190989A
Authority
AU
Australia
Prior art keywords
pathogen
produce
heterologous gene
capripoxvirus
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU41909/89A
Other versions
AU621934B2 (en
Inventor
Donald Norman Black
Christopher John Bostock
Paul David Gershon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUTE FOR ANIMAL HEALTH Ltd
Original Assignee
INSTITUTE FOR ANIMAL HEALTH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSTITUTE FOR ANIMAL HEALTH Ltd filed Critical INSTITUTE FOR ANIMAL HEALTH Ltd
Publication of AU4190989A publication Critical patent/AU4190989A/en
Application granted granted Critical
Publication of AU621934B2 publication Critical patent/AU621934B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU41909/89A 1988-08-20 1989-08-18 Insertion of heterologous gene from a pathogen to produce a recombinant capripoxvirus Ceased AU621934B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8819836 1988-08-20
GB8819836A GB2222165B (en) 1988-08-20 1988-08-20 Recombinant capripoxvirus

Publications (2)

Publication Number Publication Date
AU4190989A true AU4190989A (en) 1990-03-23
AU621934B2 AU621934B2 (en) 1992-03-26

Family

ID=10642474

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41909/89A Ceased AU621934B2 (en) 1988-08-20 1989-08-18 Insertion of heterologous gene from a pathogen to produce a recombinant capripoxvirus

Country Status (6)

Country Link
EP (1) EP0432196A1 (en)
AU (1) AU621934B2 (en)
GB (1) GB2222165B (en)
OA (1) OA09636A (en)
WO (1) WO1990002190A1 (en)
ZA (1) ZA896372B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602790B1 (en) * 1986-08-13 1990-06-01 Transgene Sa EXPRESSION OF A SPECIFIC TUMOR ANTIGEN BY A RECOMBINANT VECTOR VIRUS AND USE THEREOF FOR THE PREVENTIVE OR CURATIVE TREATMENT OF THE CORRESPONDING TUMOR
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
EP0261940A3 (en) * 1986-09-23 1989-07-05 Applied Biotechnology, Inc. Pseudorabies vaccines and dna vectors for recombination with pox viruses

Also Published As

Publication number Publication date
WO1990002190A1 (en) 1990-03-08
GB8819836D0 (en) 1988-09-21
AU621934B2 (en) 1992-03-26
EP0432196A1 (en) 1991-06-19
ZA896372B (en) 1990-07-25
GB2222165A (en) 1990-02-28
GB2222165B (en) 1992-06-17
OA09636A (en) 1993-04-30

Similar Documents

Publication Publication Date Title
AU1376688A (en) Recombinant avipoxvirus
AU7831787A (en) Improved recombinant expression
AU2732088A (en) Non-reusable syringe
AU3438589A (en) Novel cyclopentano-vitamin d analogs
AU2222888A (en) Recombinant avipoxvirus
AU4325089A (en) Viral vaccines
AU1615188A (en) Proteins having a TNF action
AU1614688A (en) A phosphinothricin-resistance gene
AU5315890A (en) Novel substituted phosphonic acids and esters
AU6259590A (en) Enhanced gene expression in response to lactation signals
AU3006789A (en) Expression of hiv binding proteins
AU7073387A (en) Nodulation inducing factors
AU4503689A (en) Yeast heat shock protein 60 and analogs
AU4190989A (en) Insertion of heterologous gene from a pathogen to produce a recombinant capripoxvirus
AU635036B2 (en) Recombinant avipoxvirus
AU3040989A (en) A game
AU3370789A (en) A dental cement
AU3886189A (en) Improvements relating to infusion devices
AU6278286A (en) Piezoelectric ceramic
AU1374688A (en) A game
AU8294687A (en) A blast furnace
AU4080485A (en) Activated hbsag vaccine
AU4974190A (en) Improvements relating to arch setting
AU3709389A (en) Binding of basic refractories
AU6453786A (en) Phosphonic esters